Saskatchewan’s initial supply of 2,500 single dose Janssen (Johnson & Johnson) vaccines will be administered through a number of Saskatchewan Health Authority (SHA) clinics starting Wednesday, November 17. 


These clinics are scheduled for Regina, Saskatoon, Estevan, Prince Albert, Melfort, Swift Current, North Battleford and Lloydminster.  Note that inclement weather may delay vaccine deliveries, and additional clinic locations are planned. 


All residents are asked to check the SHA clinic location information online for the most current list of locations, dates and times before travelling.


Janssen is available to residents 18 years of age and older.  Due to the limited number of doses received and potential demand, these doses will be available on a walk-in basis at these locations only.  Janssen appointments cannot be booked online through the Patient Booking System. 


SHA clinics will be set up to permit walk-ins to be screened to receive Janssen upon request. Due to limited supply, Janssen immunizations will be based on first come, first served and available at these locations until supply is utilized. 


Fourteen days following a Janssen vaccination, you may download and present your MySaskHealth Record QR code or wallet card with required identification as proof of vaccination.  


Note that Janssen is not available as a booster/third dose.  Janssen single dose vaccine recipients will be eligible for a booster dose two months following their vaccination and recipients will have an mRNA vaccine (Moderna or Pfizer) available to them.  Approved by Health Canada, it is safe to mix vaccine types and has shown to improve overall immune response to COVID-19.  

About the Janssen (Johnson & Johnson) Vaccine

Janssen (Johnson & Johnson) is a single dose, viral vector COVID-19 vaccine approved for use in Canada by Health Canada.  The recipient of Janssen vaccines are considered “fully vaccinated” 14 days after receiving their single dose.  This is the time required for the body to develop the protective immune response.


A viral vector vaccine uses a piece of a modified virus to generate an immune response but note that it is not the virus that causes COVID-19.  In the clinical trials, the Janssen vaccine had high efficacy at preventing hospitalization and death in people who did contract COVID-19. The potential side effects from receiving this vaccine are similar to all COVID-19 vaccines. 


For more information on Janssen (Johnson & Johnson), see the product information posted at


General COVID-19 Information


General public inquiries may be directed to